CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
To assess:* efficacy of APL-101 as monotherapy for the treatment of NSCLC harboring MET Exon 14 skipping mutations, NSCLC harboring MET amplification...
Phase 2
Budapest, Hungary and 41 other locations
The main purpose of this study is to demonstrate the superiority of S 95005 in combination with bevacizumab over capecitabine in combination with bev...
Phase 3
Budapest, Hungary and 189 other locations
Phase 1 dose escalation will determine the first cycle dose-limiting toxicities (DLTs), the maximum tolerated dose (MTD), the biologically effective...
Phase 1, Phase 2
Budapest, Hungary and 163 other locations
Clinical trials
Research sites
Resources
Legal